Blinded, Long-Term Safety and Efficacy of Tadalafil in Treatment for Pulmonary Arterial Hypertension

被引:0
|
作者
Oudiz, R. J. [1 ]
Beardsworth, A. [2 ]
Chan, M. L. S. [2 ]
Barst, R. J. [3 ]
机构
[1] Univ Calif Los Angeles, Los Angeles Biomed Res Inst Harbor, Torrance, CA USA
[2] Lilly Res Labs, Indianapolis, IN USA
[3] Columbia Univ, New York, NY USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1042
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Frost, Adaani E.
    Barst, Robyn J.
    Hoeper, Marius M.
    Chang, Hyuk-Jae
    Frantz, Robert P.
    Fukumoto, Yoshihiro
    Galie, Nazzareno
    Hassoun, Paul M.
    Klose, Hans
    Matsubara, Hiromi
    Morrell, Nicholas W.
    Peacock, Andrew J.
    Pfeifer, Michael
    Simonneau, Gerald
    Tapson, Victor F.
    Torres, Fernando
    Vizza, Carmine Dario
    Lawrence, David
    Yang, Wei
    Felser, James M.
    Quinn, Deborah A.
    Ghofrani, Hossein-Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (11): : 1366 - 1375
  • [2] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Hoeper, Marius
    Barst, Robyn
    Galie, Nazzareno
    Hassoun, Paul
    Morrell, Nicholas
    Peacock, Andrew
    Simonneau, Gerald
    Tapson, Victor
    Torres, Fernando
    Lawrence, David
    Quinn, Deborah
    Ghofrani, Hossein Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension
    Speich, Rudolf
    Ulrich, Silvia
    Domenighetti, Guido
    Huber, Lars C.
    Fischler, Manuel
    Treder, Ursula
    Breitenste, Alexander
    RESPIRATION, 2015, 89 (06) : 515 - 524
  • [4] Safety and Long-Term Efficacy of Transition from Sildenafil to Tadalafil due to Side Effects in Patients with Pulmonary Arterial Hypertension
    Mona Lichtblau
    Dominik Harzheim
    Nicola Ehlken
    Alberto Marra
    Fabiola Pena Pinado
    Ekkehard Grünig
    Benjamin Egenlauf
    Lung, 2015, 193 : 105 - 112
  • [5] Safety and Long-Term Efficacy of Transition from Sildenafil to Tadalafil due to Side Effects in Patients with Pulmonary Arterial Hypertension
    Lichtblau, Mona
    Harzheim, Dominik
    Ehlken, Nicola
    Marra, Alberto
    Pinado, Fabiola Pena
    Gruenig, Ekkehard
    Egenlauf, Benjamin
    LUNG, 2015, 193 (01) : 105 - 112
  • [6] Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
    Hislop, A. A.
    Moledina, S.
    Foster, H.
    Schulze-Neick, I.
    Haworth, S. G.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (01) : 70 - 77
  • [7] LONG-TERM EFFICACY AND SAFETY OF SPIRONOLACTONE IN THE TREATMENT OF RESISTANT ARTERIAL HYPERTENSION
    Vaclavik, Jan
    Jelinek, Libor
    Jarkovsky, Jiri
    Benesova, Klara
    Ramik, Zdenek
    Kamasova, Monika
    Kocianova, Eva
    Vykoupil, Karel
    JOURNAL OF HYPERTENSION, 2021, 39 : E355 - E355
  • [8] Long-term safety and efficacy of ambrisentan in Japanese adults with pulmonary arterial hypertension
    Yoshida, Shunji
    Shirato, Kunio
    Shimamura, Ryutaro
    Iwase, Takayuki
    Aoyagi, Narumi
    Nakajima, Hiromu
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1069 - 1076
  • [9] Long-term treatment of pulmonary arterial hypertension with treprostinil: Echocardiographic evaluation of efficacy
    Zwicke, D
    Lobacz, D
    Johnson, L
    Wade, M
    Roscigno, R
    CHEST, 2003, 124 (04) : 89S - 89S
  • [10] Tadalafil for the treatment of pulmonary arterial hypertension
    Rosenzweig, Erika B.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (01) : 127 - 132